Intelligent Bio Solutions Inc.INBSNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -20.49% | -11.52% | +15.95% | +27.46% | +47.62% |
| Gross Profit Growth | +11.98% | +91.25% | -58.85% | -38.03% | -20.29% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +377.64% | +177.50% | +73.42% | +168.77% | +109.62% |
| Weighted Average Shares Diluted Growth | +377.64% | +177.50% | +73.42% | +124.27% | +109.62% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +16.26% | +34.96% | +63.45% | +282.10% | +1514.91% |
| Inventory Growth | -25.56% | -22.15% | -18.30% | -19.21% | -15.83% |
| Asset Growth | -1.62% | -43.75% | -40.13% | -27.15% | +103.28% |
| Book Value per Share Growth | -72.13% | -83.45% | -79.26% | -83.82% | +21.21% |
| Debt Growth | -42.09% | -45.24% | -75.42% | +123.98% | +451.69% |
| R&D Expense Growth | +45.48% | -23.97% | +94.07% | -48.76% | +2.99% |
| SG&A Expenses Growth | +6.10% | -0.75% | +1.77% | +36.47% | +29.18% |